72 related articles for article (PubMed ID: 23975858)
1. The relationship between KRAS gene mutations and HLA class I antigen downregulation in the metastasis of non-small cell lung cancer.
He XP; Song FJ; Liu XY; Wang Z; Li XX; Liu FY; Chen G; Jiang WP
J Int Med Res; 2013 Oct; 41(5):1473-83. PubMed ID: 23975858
[TBL] [Abstract][Full Text] [Related]
2. The expression of circulating miR-504 in plasma is associated with EGFR mutation status in non-small-cell lung carcinoma patients.
Szpechcinski A; Florczuk M; Duk K; Zdral A; Rudzinski S; Bryl M; Czyzewicz G; Rudzinski P; Kupis W; Wojda E; Giedronowicz D; Langfort R; Barinow-Wojewodzki A; Orlowski T; Chorostowska-Wynimko J
Cell Mol Life Sci; 2019 Sep; 76(18):3641-3656. PubMed ID: 30953094
[TBL] [Abstract][Full Text] [Related]
3. High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer.
Krypuy M; Newnham GM; Thomas DM; Conron M; Dobrovic A
BMC Cancer; 2006 Dec; 6():295. PubMed ID: 17184525
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer.
Chang HC; Cho CY; Hung WC
Cancer Sci; 2007 Feb; 98(2):169-73. PubMed ID: 17233834
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the c-MET gene amplification between primary tumor and metastatic lymph nodes in non-small cell lung cancer.
Xu CW; Wang WX; Wu MJ; Zhu YC; Zhuang W; Lin G; Du KQ; Huang YJ; Chen YP; Chen G; Fang MY
Thorac Cancer; 2017 Sep; 8(5):417-422. PubMed ID: 28590585
[TBL] [Abstract][Full Text] [Related]
6. Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival?
Ramnath N; Tan D; Li Q; Hylander BL; Bogner P; Ryes L; Ferrone S
Cancer Immunol Immunother; 2006 Aug; 55(8):891-9. PubMed ID: 16187081
[TBL] [Abstract][Full Text] [Related]
7. Genetic profiles of oligometastatic non-small-cell lung cancer and corresponding brain metastases.
Werner RS; Rechsteiner M; Moch H; Curioni-Fontecedro A; Weller M; Weiss T; Regli L; Le Rhun E; Mairinger F; Opitz I; Soltermann A
Eur J Cardiothorac Surg; 2024 Jun; 65(6):. PubMed ID: 38796684
[TBL] [Abstract][Full Text] [Related]
8. [Research progress on HLA-G in non-small cell lung cancer].
Li R; Guo Z; Zhang X; Xiao L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Feb; 40(2):174-178. PubMed ID: 38284259
[TBL] [Abstract][Full Text] [Related]
9. Selective activation of p53-mediated tumour suppression in high-grade tumours.
Junttila MR; Karnezis AN; Garcia D; Madriles F; Kortlever RM; Rostker F; Brown Swigart L; Pham DM; Seo Y; Evan GI; Martins CP
Nature; 2010 Nov; 468(7323):567-71. PubMed ID: 21107427
[TBL] [Abstract][Full Text] [Related]
10. HLA-A2 antigen status predicts metastasis and response to immunotherapy in gastric cancer.
Ogoshi K; Tajima T; Mitomi T; Makuuchi H; Tsuji K
Cancer Immunol Immunother; 1997 Oct; 45(1):53-9. PubMed ID: 9353427
[TBL] [Abstract][Full Text] [Related]
11. Association of predicted pathogenic mutations in mitochondrial ND genes with distant metastasis in NSCLC and colon cancer.
Koshikawa N; Akimoto M; Hayashi JI; Nagase H; Takenaga K
Sci Rep; 2017 Nov; 7(1):15535. PubMed ID: 29138417
[TBL] [Abstract][Full Text] [Related]
12. Solitary acrometastasis of the phalanx as initial presentation of an oligometastatic Kirsten rat sarcoma viral oncogene homolog-mutated lung adenocarcinoma: a case report.
Pușcașu AI; Moinard-Butot F; Antoni D; Schott R; Somme L
J Med Case Rep; 2023 Sep; 17(1):395. PubMed ID: 37718451
[TBL] [Abstract][Full Text] [Related]
13. The Comparison of Serum Exosome Protein Profile in Diagnosis of NSCLC Patients.
Baran K; Waśko J; Kryczka J; Boncela J; Jabłoński S; Kolesińska B; Brzeziańska-Lasota E; Kordiak J
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37761972
[TBL] [Abstract][Full Text] [Related]
14. Genomic-transcriptomic evolution in lung cancer and metastasis.
Martínez-Ruiz C; Black JRM; Puttick C; Hill MS; Demeulemeester J; Larose Cadieux E; Thol K; Jones TP; Veeriah S; Naceur-Lombardelli C; Toncheva A; Prymas P; Rowan A; Ward S; Cubitt L; Athanasopoulou F; Pich O; Karasaki T; Moore DA; Salgado R; Colliver E; Castignani C; Dietzen M; Huebner A; Al Bakir M; Tanić M; Watkins TBK; Lim EL; Al-Rashed AM; Lang D; Clements J; Cook DE; Rosenthal R; Wilson GA; Frankell AM; de Carné Trécesson S; East P; Kanu N; Litchfield K; Birkbak NJ; Hackshaw A; Beck S; Van Loo P; Jamal-Hanjani M; ; Swanton C; McGranahan N
Nature; 2023 Apr; 616(7957):543-552. PubMed ID: 37046093
[TBL] [Abstract][Full Text] [Related]
15. The evolution of non-small cell lung cancer metastases in TRACERx.
Al Bakir M; Huebner A; Martínez-Ruiz C; Grigoriadis K; Watkins TBK; Pich O; Moore DA; Veeriah S; Ward S; Laycock J; Johnson D; Rowan A; Razaq M; Akther M; Naceur-Lombardelli C; Prymas P; Toncheva A; Hessey S; Dietzen M; Colliver E; Frankell AM; Bunkum A; Lim EL; Karasaki T; Abbosh C; Hiley CT; Hill MS; Cook DE; Wilson GA; Salgado R; Nye E; Stone RK; Fennell DA; Price G; Kerr KM; Naidu B; Middleton G; Summers Y; Lindsay CR; Blackhall FH; Cave J; Blyth KG; Nair A; Ahmed A; Taylor MN; Procter AJ; Falzon M; Lawrence D; Navani N; Thakrar RM; Janes SM; Papadatos-Pastos D; Forster MD; Lee SM; Ahmad T; Quezada SA; Peggs KS; Van Loo P; Dive C; Hackshaw A; Birkbak NJ; Zaccaria S; ; Jamal-Hanjani M; McGranahan N; Swanton C
Nature; 2023 Apr; 616(7957):534-542. PubMed ID: 37046095
[TBL] [Abstract][Full Text] [Related]
16. Noncanonical splicing junctions between exons and transposable elements represent a source of immunogenic recurrent neo-antigens in patients with lung cancer.
Merlotti A; Sadacca B; Arribas YA; Ngoma M; Burbage M; Goudot C; Houy A; Rocañín-Arjó A; Lalanne A; Seguin-Givelet A; Lefevre M; Heurtebise-Chrétien S; Baudon B; Oliveira G; Loew D; Carrascal M; Wu CJ; Lantz O; Stern MH; Girard N; Waterfall JJ; Amigorena S
Sci Immunol; 2023 Feb; 8(80):eabm6359. PubMed ID: 36735774
[TBL] [Abstract][Full Text] [Related]
17. Human leukocyte antigen (HLA)-G gene polymorphism in patients with non-small cell lung cancer.
Kowal A; Wiśniewski A; Kuśnierczyk P; Jankowska R
Thorac Cancer; 2015 Sep; 6(5):613-9. PubMed ID: 26445610
[TBL] [Abstract][Full Text] [Related]
18. Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors.
Wang QJ; Yu Z; Griffith K; Hanada K; Restifo NP; Yang JC
Cancer Immunol Res; 2016 Mar; 4(3):204-14. PubMed ID: 26701267
[TBL] [Abstract][Full Text] [Related]
19. HLA class I antigen processing machinery defects in antitumor immunity and immunotherapy.
Maggs L; Sadagopan A; Moghaddam AS; Ferrone S
Trends Cancer; 2021 Dec; 7(12):1089-1101. PubMed ID: 34489208
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of HLA-I in cancer and its central importance for immunotherapy.
Hazini A; Fisher K; Seymour L
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34353849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
